GP

Grand Pharma

Europe, Szabolcs-Szatmar-Bereg, Hungary, Nyíregyháza

Description

GRAND PHARMA is a pharmaceutical company that specializes in drug retailing and wholesaling.

Investor Profile

Grand Pharma has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Grand Pharma frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Novalis LifeSciences
North America, Virginia, United States, Hampton
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1

Which angels does Grand Pharma often collaborate with?

KC
North America, United States
Shared Deals: 1

What are some of recent deals done by Grand Pharma?

etherna immunotherapies

Niel, Antwerpen, Belgium

etherna develops mRNA and lipid nanoparticle solutions.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series BAug 23, 2022
Amount Raised: $38,869,747